Search results
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript May 8, 2024 Amphastar...
Insider Sell Alert: Director Richard Prins Sells 4,000 Shares of Amphastar Pharmaceuticals Inc ...
GuruFocus.com via Yahoo Finance· 7 months agoAmphastar Pharmaceuticals Inc (NASDAQ:AMPH) has recently witnessed an insider sell that has caught...
Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)
GuruFocus.com via Yahoo Finance· 4 days agoOn June 10, 2024, Floyd Petersen, Director at Amphastar Pharmaceuticals Inc (NASDAQ:AMPH), executed...
Amphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Shares
GuruFocus.com via Yahoo Finance· 3 months agoAmphastar Pharmaceuticals Inc (NASDAQ:AMPH), a company specializing in the development,...
Insider Sell: CFO William Peters Sells Shares of Amphastar Pharmaceuticals Inc
GuruFocus.com via Yahoo Finance· 7 months agoAmphastar Pharmaceuticals Inc (NASDAQ:AMPH), a company specializing in the development,...
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Fundamentals Look Pretty Strong: Could The Market Be...
Simply Wall St. via Yahoo Finance· 1 month agoAmphastar Pharmaceuticals (NASDAQ:AMPH) has had a rough three months with its share price down 19%....
Amphastar Pharmaceuticals Inc CFO, EVP & Treasurer William Peters Sells 18,136 Shares
GuruFocus.com via Yahoo Finance· 3 months agoWilliam Peters, the Chief Financial Officer, Executive Vice President, and Treasurer of Amphastar...
Institutional investors in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) lost 3.4% last week but...
Simply Wall St. via Yahoo Finance· 4 months agoKey Insights Given the large stake in the stock by institutions, Amphastar Pharmaceuticals' stock...
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is a favorite amongst institutional investors who own...
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) should be aware of the most powerful...
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is favoured by institutional owners who hold 62% of...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Significantly high institutional ownership implies Amphastar Pharmaceuticals' stock...